Q

Quince Therapeutics
D

QNCX

2.03000
USD
0.01
(0.50%)
Market Closed
Volume
7,923
EPS
-1
Div Yield
-
P/E
-2
Market Cap
89,323,335
News

Title: Quince Therapeutics

Sector: Healthcare
Industry: Biotechnology
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing innovative precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics.